Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and peptides.
View Top Employees from AdjuvatisWebsite | http://www.adjuvatis.com |
Revenue | $5 million |
Employees | 6 (6 on RocketReach) |
Founded | 2013 |
Address | 60, Avenue Rockefeller, Bâtiment Laënnec, Lyon, Auvergne-Rhône-Alpes 69008, FR |
Phone | +33 4 72 72 26 56 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Adjuvatis employee's phone or email?
The Adjuvatis annual revenue was $5 million in 2024.
David Da Costa is the COO of Adjuvatis.
6 people are employed at Adjuvatis.
Adjuvatis is based in Lyon, Auvergne-Rhône-Alpes.
The NAICS codes for Adjuvatis are [32, 325, 32541, 3254].
The SIC codes for Adjuvatis are [283, 28].